RAM
ENZ

Roumell Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Roumell Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-681,358
Closed -$1.25M – 21
2023
Q2 		$1.25M Sell
681,358
-223,954
-25% -$518K 2.46% 16
2023
Q1 		$2.2M Sell
905,312
-1,222,952
-57% -$1.82M 4.98% 10
2022
Q4 		$3.04M Sell
2,128,264
-261,947
-11% -$510K 7.54% 4
2022
Q3 		$5.33M Hold
2,390,211
– – 11.54% 2
2022
Q2 		$4.95M Sell
2,390,211
-2,431
-0.1% -$6.01K 9.63% 3
2022
Q1 		$6.94M Sell
2,392,642
-44,129
-2% -$142K 11.21% 2
2021
Q4 		$7.82M Sell
2,436,771
-450,000
-16% -$1.54M 10.43% 4
2021
Q3 		$10.2M Hold
2,886,771
– – 13.54% 2
2021
Q2 		$9.15M Buy
2,886,771
+150,052
+5% +$472K 10.69% 4
2021
Q1 		$9.41M Sell
2,736,719
-32,760
-1% -$102K 13.61% 3
2020
Q4 		$6.98M Buy
2,769,479
+415,000
+18% +$904K 10.97% 5
2020
Q3 		$4.97M Buy
2,354,479
+1,742,715
+285% +$4.14M 9.85% 6
2020
Q2 		$1.37M Buy
+611,764
New +$1.57M 3.3% 11
2019
Q3 		– Sell
-1,236,309
Closed -$4.17M – 15
2019
Q2 		$4.17M Sell
1,236,309
-662,870
-35% -$2.34M 9.86% 3
2019
Q1 		$5.18M Buy
1,899,179
+794,040
+72% +$2.6M 12.61% 1
2018
Q4 		$3.07M Buy
1,105,139
+339,855
+44% +$1.11M 6.35% 6
2018
Q3 		$3.15M Buy
+765,284
New +$3.48M 5.79% 6

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Roumell Asset Management's ENZ Position: Q3 2023 in Review

Roumell Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2023, closing a stake of 681,358 shares — an estimated $1.25M sold.

Roumell Asset Management first reported a position in ENZ in Q3 2018 and held it in 17 quarters. The position peaked at $10.2M in Q3 2021. 39 funds tracked by Wall St. Rank hold ENZ as of Q3 2023.

  • Roumell Asset Management reported no remaining Enzo Biochem, Inc. position as of Q3 2023 after selling out during the quarter.
  • Roumell Asset Management sold 681,358 Enzo Biochem, Inc. shares in Q3 2023, an estimated $1.25M.
  • Roumell Asset Management first reported a position in Enzo Biochem, Inc. in Q3 2018 and held it in 17 quarters.
  • Roumell Asset Management's Enzo Biochem, Inc. position peaked at $10.2M in Q3 2021.
  • 39 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2023.

Based on Roumell Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.